Feb 13 2026 This Week in Cardiology
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Ticagrelor vs prasugrel, a new LAAC device, pulsed field ablation AF results, lifestyle intervention in AF, the term "provider" vs "doctor," and coffee are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I TUXEDO-2 Trial
- TUXEDO-2 Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2844869
- ISAR-REACT 5 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1908973
II VERITAS Study of Dual-Seal LAAO
- VERITAS Study https://doi.org/10.1016/j.jacep.2026.01.021
III PFA vs RF over 4 years
- Advent-LTO study https://www.nature.com/articles/s41591-026-04246-4
- ADVENT Study https://www.nejm.org/doi/full/10.1056/NEJMoa2307291
- SPHERE PER-AF Study https://www.nature.com/articles/s41591-024-03022-6
SINGLE SHOT CHAMPION Study https://www.nejm.org/doi/full/10.1056/NEJMoa2502280 - BEAT PAROX-AF Trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf1115/8436829
IV What's in a Name — Use of the Term "Provider"
- Physicians Are Not Providers: The Ethical Significance of Names https://www.acpjournals.org/doi/10.7326/ANNALS-25-03852
V Coffee and Dementia Risk
- Coffee/Tea Intake and Dementia Risk https://jamanetwork.com/journals/jama/fullarticle/2844764
- Mandrola Commentary: Enough With the Coffee Research and Other Distractions https://www.medscape.com/viewarticle/883709
VI Lifestyle interventions Post AF ablation
- Improving Outcomes of AF by Lifestyle Interventions https://academic.oup.com/eurheartj/article/47/6/669/8243674
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net